Director/PDMR Shareholding

RNS Number : 4957S

SkinBioTherapeutics PLC

09 March 2023

 

9 March 2023

SkinBioTherapeutics plc

("SBTX" or the "Company")  

Director Bed & ISA Dealings

SkinBioTherapeutics plc (AIM: SBTX), the life science company focused on skin health , announces that it received notification on 9 March 2023 that Stuart Ashman , CEO and PDMR , sold 89,472 ordinary shares of 1p each in the Company ("Ordinary Shares") and repurchased 86,387 Ordinary Shares into Mr Ashman's ISA account.  Following this transaction Stuart Ashman's beneficial interest in the Company shares has decreased from 281,250 to 278,165 ordinary shares, with the variance owing to commissions and costs of the transactions .

Details of PDMR transaction

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Stuart Ashman
2	Reason for the notification
a)	Position/status	PDMR (CEO)
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	SkinBioTherapeutics plc
b)	LEI	213800YMQOCB23FX6I06
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares in SkinBioTherapeutics plc
	Identification code	GB00BF33H870
b)	Nature of the transaction	Sale and purchase of ordinary shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Sale at 22.75 p	89,472
			Purchase at 22.75 p	86,387
d)	Aggregated information
	- Aggregated volume	n/a
	- Price
e)	Date of the transactions	6 March 2023
f)	Place of the transaction	N/A

 

END

 

 

DSHQKLFBXXLEBBX